No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Oral
-
Eosinophilia / drug therapy*
-
Eosinophilia / genetics
-
Humans
-
Lymphoma / drug therapy*
-
Lymphoma / genetics
-
Male
-
Middle Aged
-
Myeloproliferative Disorders / drug therapy*
-
Myeloproliferative Disorders / genetics
-
Oncogene Proteins, Fusion / genetics*
-
Protein Kinase Inhibitors / pharmacology
-
Protein Kinase Inhibitors / therapeutic use*
-
Receptor, Fibroblast Growth Factor, Type 1 / antagonists & inhibitors*
-
Receptor, Fibroblast Growth Factor, Type 1 / genetics*
-
Treatment Outcome
Substances
-
Oncogene Proteins, Fusion
-
Protein Kinase Inhibitors
-
FGFR1 protein, human
-
Receptor, Fibroblast Growth Factor, Type 1
-
CEP110-FGFR1 fusion protein, human
Supplementary concepts
-
Myeloproliferative Disorder, Chronic, with Eosinophilia